Robert S. Daly

Pulmonary Medicine

1250 E County Line Rd Ste 2
Indianapolis, IN 46227

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial.

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: March 10, 2018

Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.

Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma.

Journal: Future oncology (London, England)

Published: April 21, 2016

Showing 1-2 of 2

Last Updated: 09/26/2026